Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Graefen

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Der Urologe. Ausg. A|May 1, 1998
[Plasma TGF-beta1 concentrations in patients with prostate carcinoma or benign prostatic hyperplasia]I Lange, P Hammerer, C Knabbe, et al.
The Journal of Urology|November 20, 1997
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasiaA Haese, M Graefen, J Noldus, et al.
Der Urologe. Ausg. A|March 19, 2010
[Type and extent of preoperative imaging before radical prostatectomy]H Isbarn, S Kellermann, G Salomon, et al.
The Journal of Urology|March 19, 1999
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomyA Haese, E Huland, M Graefen, et al.
Actas Urologicas Espanolas|July 25, 2012
[Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations]D Mitropoulos, W Artibani, M Graefen, et al.
Urologie (Heidelberg, Germany)|March 6, 2023
[The interoperability of IIEF-5 with EPIC-26 : Sexual function after radical prostatectomy]F Fischer, C Kowalski, J Simon, et al.
The Journal of Urology|May 23, 1998
The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancerJ Noldus, M Graefen, E Huland, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|June 1, 2017
Early clinical experience with water-jet dissection (hydro-jet) during nerve-sparing radical retropubic prostatectomyS Fernández De la Maza, S Conrad, M Graefen, et al.
Der Urologe. Ausg. A|May 30, 2018
[Metronomic chemotherapy with oral cyclophosphamide : An individual option for the metastatic castration-resistant prostate cancer patient?]S Knipper, P Mandel, G V Amsberg, et al.
European Urology|June 22, 2000
Stage migration in clinically localized prostate cancerJ Noldus, M Graefen, A Haese, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Der Urologe. Ausg. A|May 1, 1998
[Plasma TGF-beta1 concentrations in patients with prostate carcinoma or benign prostatic hyperplasia]I Lange, P Hammerer, C Knabbe, et al.
The Journal of Urology|November 20, 1997
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasiaA Haese, M Graefen, J Noldus, et al.
Der Urologe. Ausg. A|March 19, 2010
[Type and extent of preoperative imaging before radical prostatectomy]H Isbarn, S Kellermann, G Salomon, et al.
The Journal of Urology|March 19, 1999
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomyA Haese, E Huland, M Graefen, et al.
Actas Urologicas Espanolas|July 25, 2012
[Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations]D Mitropoulos, W Artibani, M Graefen, et al.
Urologie (Heidelberg, Germany)|March 6, 2023
[The interoperability of IIEF-5 with EPIC-26 : Sexual function after radical prostatectomy]F Fischer, C Kowalski, J Simon, et al.
The Journal of Urology|May 23, 1998
The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancerJ Noldus, M Graefen, E Huland, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|June 1, 2017
Early clinical experience with water-jet dissection (hydro-jet) during nerve-sparing radical retropubic prostatectomyS Fernández De la Maza, S Conrad, M Graefen, et al.
Der Urologe. Ausg. A|May 30, 2018
[Metronomic chemotherapy with oral cyclophosphamide : An individual option for the metastatic castration-resistant prostate cancer patient?]S Knipper, P Mandel, G V Amsberg, et al.
European Urology|June 22, 2000
Stage migration in clinically localized prostate cancerJ Noldus, M Graefen, A Haese, et al.
Pageof 12